GWSAF yields 1968.50% · JNJ yields 2.13%● Live data
📍 GWSAF pulled ahead of the other in Year 1
Combined, GWSAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GWSAF + JNJ for your $10,000?
Gowest Gold Ltd. operates as a gold exploration and development company in Canada. The company focuses on the development of its 100% owned Bradshaw gold deposit, which is part of the North Timmins gold project located near Timmins, Ontario. It holds interest in the North Timmins Gold Project that covers 1 patented mining claim, 11 mining leases, and 56 unpatented mining claims covering an area of approximately 11,185 hectares in Evelyn, Gowan, Little, Prosser, Tully, and Wark Townships in the Timmins gold camp. The company also holds interest in the Frankfield Property, which comprise 9 mining leases covering an area of 837 hectares; and 67.7% interest in the Pipestone Property consisting of two blocks covering an area of approximately 7,577 hectares. In addition, it holds 100% interest in the Tully Property that consists of two claim blocks covering an area of approximately 2,513 hectares located in Tully Township; and the Gowest Whitney Property, which consists of nine patented claims covering an area of approximately 144 hectares located in Timmins, Ontario. The company was formerly known as Gowest Amalgamated Resources Ltd. and changed its name to Gowest Gold Ltd. in March 2011. Gowest Gold Ltd. is headquartered in Toronto, Canada.
Full GWSAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.